|
Mitomycin Clinical Trials
8 actively recruiting trials across 6 locations
Also known as: Ametycine, Jelmyto, MITO, Mito-C, Mito-Medac +13 more
Pipeline
Phase 1: 1Phase 2: 5Phase 3: 1Phase 1/2: 1
Top Sponsors
- National Cancer Institute (NCI)2
- City of Hope Medical Center2
- University of Chicago1
- Roland Seiler-Blarer1
- NRG Oncology1
Indications
- Cancer8
- Stage I Bladder Cancer AJCC v82
- Peritoneal Carcinomatosis2
- Stage IVC Appendix Carcinoma AJCC v81
- Stage IVB Appendix Carcinoma AJCC v81
Duarte, California2 trials
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
Phase 1
Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
Phase 2
Other1 trial
Fort Smith, Arkansas1 trial
Bakersfield, California1 trial
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
AIS Cancer Center at San Joaquin Community Hospital
Phase 2
San Francisco, California1 trial
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
Zuckerberg San Francisco General Hospital
Phase 2
Jacksonville, Florida1 trial
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Mayo Clinic in Florida
Phase 1/2
Chicago, Illinois1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.